Please try another search
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
Name | Age | Since | Title |
---|---|---|---|
Tamar Raz | 60 | 2014 | Chairman of the Board |
Merav Kaye | 51 | 2014 | Director |
Doron Nevo | 69 | 2018 | Independent External Director |
Erez Waiter | 67 | 2016 | Director |
Nurit Toiser Zacks | 59 | 2021 | Independent External Director |
Yuval Adar | 52 | 2021 | Director |
Asher Alhiani | 72 | 2022 | Director |
Eliane Markowitz | 61 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review